Health and Medicine

Course "eCTD Submissions of IND/NDA to the US FDA, EU and Canada" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion. Overview: The international agreement to assemble all Quality, Safety and Efficacy information for a drug or biologic product into a common format (called the CTD - Common Technical Document) has improved the speed and efficiency for companies working in global development programs and clarified expectations by regulatory bodies. Reformatting for multiple submissions is substantially limited. The CTD has improved the regulatory review processes and enabled implementation of good…

Course "Evolution of the Quality Management System - How to go from Surviving to Thriving" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion. Overview: Using lecture, discussion, and exercises, this 2 day seminar will focus on taking your QMS from surviving to thriving. We'll move from understanding the regulatory requirements, how to create your QMS structure, process thinking, and developing your improvement strategy. We'll discuss tools and techniques for improvement and how to measure your progress. Why you should attend: Many companies struggle to establish and maintain a…

As the demand for information outside of approved labeling continues to rise, the FDA has been called by the industry to provide guidance that governs off-label communications. The regulatory landscape that monitors this space is often blamed for limiting the amount of information received by patients and restricting their ability to make well-informed decisions. Given the public health issues at stake and the public interest involved, it is imperative that this event details the importance of the timely communication of truthful scientific information that currently challenges pharmaceutical, biotech, and medical device professionals. The 2018 Off-Label Regulatory Compliance Congress also explores…

This three-day symposium is designed to provide a comprehensive understanding of the anatomy, clinical aspects, imaging, and management of patients with congenital heart disease. The symposium will include case discussions, didactic seminars, anatomic and imaging correlations, discussion of multimodal imaging and live, hands-on scanning seminars to illustrate the impact of cardiac imaging on treatment, diagnosis, and management of patients with congenital heart disease. URL: Booking: https://go.evvnt.com/197352-1?pid=154 Prices: MD, PhD, DO, PharmD: USD 755 Residents, Sonographers, RN: USD 620 LATE FEE-MD, PhD, DO, PharmD: USD 855 LATE FEE-Residents, Sonographers, RN: USD 720 Time: 7:30 am to 11:45 am

The use of biophysical methods has become pervasive in the drug discovery process, allowing not only to identify low-affinity hits at the screening stage but also to obtain detailed information on target / ligand interactions at more advanced stages (see the review Renaud et al. 2016 Nat. Rev. Drug Discov. 15: 679-698). This is perfectly illustrated by the success of FBDD (fragment-based drug design), where the progress of biophysical techniques in terms of sensitivity, speed, and automation has been instrumental (see the review Erlanson et al. 2016 Nat. Rev. Drug Discov. 15: 605-619). Indeed FBDD is now widely adopted in…

Join Oxford Global for the 2nd Annual Artificial Intelligence in Drug Development Congress, 25-26 September 2018, London where over 250 artificial intelligence and pharmaceutical IT attendees with represent leading biotech companies, global pharmaceutical organisations and internationally renowned academic institutions. Across two days, we will bring together 30 presentations and case studies focussed on the innovatice application of artificial intelligence in drug discovery and discovery chemistry, alongside machine learning in clinical trials and cloud computing. Including 3 interactive streams: • AI in Drug Discovery and Discovery Chemistry • Machine Learning and Personalising Patient Treatments • AI in Big Data and Clinical…

Join Oxford Global for the 16th Annual Pharmaceutical IT Congress, 25-26 September 2018, London where over 250 attendees will be representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions. Across two days, we will bring together 27 presentations and case studies focusing on the key development in Big Data, R&D informatics, translation informatics, NGS informatics and bioinformatics, and real-world evidence and real-world data. Including 3 interactive streams: • Big Data Led Strategies & Innovation • R&D Informatics, Translational Informatics, NGS Informatics and Bioinformatics • Management of Real-World Evidence and Real-World Data View Agenda: http://bit.ly/2nLs4cc For further information…

In order to present at the 2nd International Conference on Food Quality, Safety and Security 2018 you have to send your abstract on or before the abstract submission deadline. The abstract must first pass a blind peer review and if accepted by the reviewer, we will send you the abstract acceptance notification. Upon payment of the registration fee, your presentation will be confirmed. Registrations must be done online(https://foodsecurityconference.co/online-registration/), and those who register on or before the Early Bird deadline may enjoy special discounted rate in terms of registration fees(https://foodsecurityconference.co/registration-fees/).

The program consists primarily of clinical cases which illustrate the problems cardiovascular specialists commonly encounter. Multiple choice questions addressing the clinical utility and limitations of echocardiography follow each case. Utilization of cardiac CT and MRI is also incorporated into the cases. In addition, faculty presents “rapid fire” and “unknown” cases. Special breakout sessions are devoted to the interpretation of Doppler hemodynamics, diastolic function, stress echocardiography, congenital heart disease, interventional, heart failure, CT/MRI, and perioperative echocardiography. Attendees have the opportunity to share an interesting case with the faculty and audience. If you would like to share an interesting case, please make…

This is your first and only opportunity to listen to the most advanced clinical case studies from Nektar Therapeutics and Amgen which explore the use of IL-2 to enhance the expansion and activation of the Treg cells. Delve deeper with expert insights from Roche and ILTOO Pharma to understand how IL-2 at low doses could selectively stimulate Treg cells. Identify yourself as a leader in this community and join the discussion exploring the challenges in translating a proof of concept in autoimmune therapies from animal models to clinic. This meeting will provide the platform for conversations to be had to…

14 expert speakers from across Europe will summarize the most relevant scientific information for practitioners to implement into their daily work. A complete take-home compendium, including all presentations, will be handed out at the congress. The Nephro Update Europe also provides many opportunities to interact with experts in their fields; during the lecture, in the Speaker's Corner and during Interactive Case Discussions. 2018 lectures include: -Hot Topic: Hepatitis C -Glomerulonephritis -Chronic Kidney Disease -Bone and Mineral Disease -Renal Anemia -Hypertension -Cardiovascular Disease -Acute Kidney Injury -Systemic Autoimmune Diseases -Diabetic Nephropathy -Hemodialysis -Genetic Diseases -Peritoneal Dialysis -Transplantation Following 12 successful years…

The Digital Pharma Series in THE educational and networking choice for life science marketing innovators. This conference will profile best-in-class case studies and senior-level discussions that will allow you to navigate the challenges involved in modernising your business model in order to better engage with a rapidly evolving customer base. There have already been many evolutions in the marketplace and indeed how life science companies are transforming their business models to cater to the evolved customer base and economic climate. Though there are some exciting potential solutions on the horizon, there are still many questions being asked: - How will…

The AACC Middle East has been designed to provide a comprehensive overview of selected relevant topics in the
eld of clinical laboratory medicine presented by renowned international and national speakers. The AACC is considered a great chance for the attendees to update their knowledge, stimulate collaboration with each other’s and exchange experiences with distinguished line-up of experts. The AACC 2018 Abu Dhabi is expected to be an exciting venue to hear and discuss the latest scienti
c advances in all disciplines pertinent to the
eld of laboratory medicine including laboratory quality management and accreditation, clinical chemistry, newborn screening, genetics, oncology and…

The Digital Pharma Series in THE educational and networking choice for life science marketing innovators. This conference will profile best-in-class case studies and senior-level discussions that will allow you to navigate the challenges involved in modernising your business model in order to better engage with a rapidly evolving customer base. There have already been many evolutions in the marketplace and indeed how life science companies are transforming their business models to cater to the evolved customer base and economic climate. Though there are some exciting potential solutions on the horizon, there are still many questions being asked: - How will…

SMi proudly hosts the Pharmaceutical Microbiology Conference, San Diego, USA on the 7th and 8th of June 2018. This is the second Pharmaceutical Microbiology Conference we have run with last year being a great success. The pharmaceutical microbiology field is relevant in almost all areas of pharmaceuticals. This Conference provides an opportunity for professionals within the field to update themselves on the revised regulations and newly emerging methods and practices. Join us in discussing the evolving issues facing the industry, such as: aseptic practice and contamination prevention, mycoplasma testing, water monitoring and biofilms. BENEFITS OF ATTENDING: • Take part in…

At this uncertain time, the 8th annual Clinical Biomarkers And World CDx Europe Summit is back once again to provide much need clarity for pharmaceutical, biotech, healthcare and diagnostic leaders in the precision medicine industry. The event will provide you with the insight needed to successfully validate and apply patient stratifying biomarkers to boost the approval, launch and adoption of targeted therapies. http://worldcdx-europe.com/ URLs: Brochure: https://go.evvnt.com/195203-1?pid=154 Booking: https://go.evvnt.com/195203-2?pid=154 Prices: Drug Developer Conference Earlybird (Book by 09/02/18): GBP 1299 Drug Developer Conference (Standard rate): GBP 1699 Service Provider Conference Earlybird (Book by 09/02/18): GBP 1699 Service Provider Conference (Standard rate): GBP…

Pharmacology 2018 welcomes attendees, presenters, and exhibitors from all over the world to Tokyo, Japan. The event brings together truly innovative thinkers who are leading the way through current perspectives in drug research and development. We are delighted to invite you to attend and register for the “International Conference on Pharmacology” (Pharmacology 2018) which is going to be held during June 18-20, 2018 at Tokyo Japan. The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the…

OVERVIEW Because the Anti-Kickback Statute is so broad it what it proscribes, healthcare organizations, conducting what would be normal marketing activities in other industries, have run afoul of the Statute on numerous occasions. The Statute and the regulations only tell part of the story. This program will review not only the Statute and its safe harbors, but will provide an in-depth overview of OIG guidance and advisory opinions dealing with marketing activities, as well as a review of case law regarding marketing behavior. WHY SHOULD YOU ATTEND If your organization, be it a hospital, physician practice, DME provider, or any…

Founded in 2008 by a group of pioneering surgeons, ISHA through its annual meeting and dedicated funds for research, was the catalyst for the development of knowledge on non-arthritic hip pathologies and their arthroscopic treatment. ISHA has always pushed for the development of new technologies and practices for the best treatment of non-arthritic hip pathologies, as well as embracing open hip preservation surgery. The arthroscope and the development of imaging associated with anatomical, biomechanical and clinical research, made it possible to progress phenomenally rapidly in the discovery and management of unknown hip and periarticular pathologies. The 10th ISHA annual meeting,…

The program is designed to provide the basic information and principles of superficial head and neck anatomy and surgery. Each participant will utilize fresh cadaver material. Thirty-five years ago, Superficial Anatomy and Cutaneous Surgery was conceived as a course which would be beneficial to dermatologists, dermatologic surgeons and other physicians. The course has developed over the years as we continue to remain on the leading edge of cutaneous surgery. We have received many awards and compliments, which are a reflection of the efforts of our superb faculty and staff, many of whom have been coming year after year. They have…